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Brain zinc chelation by 
diethyldithiocarbamate increased 
the behavioral and mitochondrial 
damages in zebrafish subjected to 
hypoxia
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Renato D. Dias1,3, Diogo L. Oliveira1,3,6, João Batista T. Rocha5 & Diogo O. Souza1,3,6
The increase in brain levels of chelatable zinc (Zn) in dysfunctions involving oxygen deprivation has 
stimulated the treatment with Zn chelators, such as diethyldithiocarbamate (DEDTC). However, DEDTC 
is a redox-active compound and it should be better evaluated during hypoxia. We use the hypoxia model 
in zebrafish to evaluate DEDTC effects. The exploratory behavior, chelatable Zn content, activities of 
mitochondrial dehydrogenases, reactive species levels (nitric oxide, superoxide anion, hydroxyl radical 
scavenger capacity) and cellular antioxidants (sulfhydryl, superoxide dismutase) of zebrafish brain were 
assessed after recovery, with or without 0.2 mM DEDTC. The increased brain levels of chelatable Zn 
induced by hypoxia were mitigated by DEDTC. However, the novel tank task indicated that DEDTC did 
further enhance the exploratory deficit caused by hypoxia. Furthermore, these behavioral impairments 
caused by DEDTC were more associated with a negative action on mitochondrial activity and brain 
oxidative balance. Thus, due to apparent pro-oxidant action of DEDTC, our data do not support its use 
for neuroprotection in neuropathologies involving oxygen deprivation.
Zinc (Zn) is a metal abundantly found in the central nervous system (CNS)1. Despite the most part of Zn is usu-
ally bound to proteins, about 20% of total Zn is free or loosely bound to biomolecules in the brain2, both corre-
sponding to the content of Zn susceptible to chelation. Chelatable Zn presents an important function to synaptic 
physiology, acting as neuromodulator on several molecular targets3. However, the accumulation of chelatable Zn 
in brain tissue may occur during ischemic stroke and hypoxic episodes, leading to oxidative stress and inflamma-
tory response4,5. For this reason, the use of Zn chelators has been considered to mitigate the increased Zn levels 
during these brain dysfunctions5,6.
In particular, the diethyldithiocarbamate (DEDTC) is a chelator highly selective for Zn7 able to cross the 
blood-brain barrier8. Previous studies showed that DEDTC is beneficial against several disorders9,10. Due to 
Zn-binding properties, it has been suggested that DEDTC may play a neuroprotective role against hypoxia. 
However, the application of DEDTC as protective drug must be thoroughly investigated, since it is a redox-active 
compound that may impair cellular antioxidant/oxidant homeostasis11,12.
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The use of a recent model of severe hypoxia in adult zebrafish13 emerges as a useful strategy to evaluate the 
mechanisms triggered by DEDTC on cerebral dysfunctions involving oxygen (O2) deprivation. As advantages, 
the use of zebrafish allows the researcher to investigate the effects of several drugs on large scale manner in 
a non-invasive model of hypoxic condition. Previous studies have shown that the hypoxia model in zebrafish 
causes brain damage similar to those triggered by hypoxia and ischemia in mammals13,14. Additionally, behav-
ioral impairments and changes on brain mitochondrial function were also observed in fish 1 h after hypoxia14, 
representing a more refined protocol when compared to those described for rodents. The induction of hypoxia 
in zebrafish has been employed to evaluate the effects of DEDTC on the increased levels of chelatable Zn15. Thus, 
additional investigation using this model could straightforward the role of DEDTC on behavioral functions and 
oxidative status triggered by hypoxia.
Here, we evaluated whether the decrease in brain chelatable Zn performed by DEDTC improves the behav-
ioral impairment and mitochondrial damage induced by hypoxia in zebrafish. Moreover, brain oxidative status 
afforded by DEDTC was investigated.
Results
Brain Chelatable Zn. Two-way ANOVA analysis showed a significant effect of hypoxia (F[3, 9] = 16.723; 
p = 0.003) and DEDTC (F[3, 9] = 5.281; p = 0.046) on the levels of chelatable Zn in brain tissue (n = 3–4 
per group). The histochemical staining (Fig. 1A) and the optical density quantification of the periventricu-
lar gray zone (PGz) (Fig. 1B) demonstrated that hypoxia significantly increased chelatable Zn content in PGz 
(HYP1). However, DEDTC treatment attenuated the enhancement of chelatable Zn levels induced by hypoxia 
(HYP1 + DEDTC group). Moreover, DEDTC alone did not promote significant changes on chelatable Zn content.
Behavioral Activity. The behavioral profiles of each group (n = 9–12 per group) are depicted as representa-
tive track plots (Fig. 2A). The animals kept on normoxia (NOR1) presented normal exploratory activity in all parts 
of the test tank during the trial. The individual swimming traces showed a marked reduction of exploratory activ-
ity in animals subjected to hypoxia (HYP1). However, fish subjected to hypoxia followed by exposure to DEDTC 
(HYP1 + DEDTC) exhibited a more intense decline in exploratory activity, a similar result observed in animals 
treated only with DEDTC. The occupancy plots (Fig. 2B) revealed a similar spatio-temporal exploration among 
groups, but DEDTC-treated groups showed a trend to decrease the swimming at the upper half of the apparatus. 
Two-way ANOVA indicated a significant effect of hypoxia on distance travelled (F[3, 39] = 4.576; p = 0.038) and 
turn angle (F[3, 39] = 4.126; p = 0.049) (Fig. 3A). Contrastingly, DEDTC significantly altered locomotion-related 
parameters, as time mobile (F[3, 39] = 11.286; p = 0.002), distance travelled (F[3, 39] = 33.898; p < 0.001), turn 
angle (F[3, 39] = 18.266; p < 0.001), and meandering (F[3, 39] = 21.623; p < 0.001). Post-hoc comparisons 
showed that although both HYP1 and HYP1 + DEDTC groups did not present significant changes in time mobile 
(Fig. 3A), DEDTC exposure per se caused a decrease in this parameter. The animals subjected to hypoxia (HYP1) 
also presented a markedly reduction in the distance travelled and turn angle (Fig. 3A). The administration of 
DEDTC after hypoxia episode (HYP1 + DEDTC) did not reverse these effects and also decreased the distance 
travelled, as observed in the DEDTC group. In addition, the hypoxia episode (HYP1) caused no changes on 
meandering (Fig. 3A), while both DEDTC-treated groups (DEDTC and HYP1 + DEDTC) increased the respec-
tive parameter.
The analysis of the vertical exploration showed that the time spent in bottom and top areas did not signifi-
cantly change (data not shown). Furthermore, the transitions to the top and bottom areas (Fig. 3B) were unaltered 
Figure 1. Chelatable Zn in the PGz of zebrafish brain stained by Neo-Timm after hypoxia followed by 
normoxic treatment, with or without DEDTC. (A) Chelatable Zn staining. Images in lower panels represent 
higher magnification of the area delimited by the square depicted in upper panels. The higher chelatable Zn 
content is indicated by the presence of the darker granules. (B) Optic densities of periventricular gray zone. OT, 
optic tectum; PGz, periventricular gray zone. Bars represent 200 μ m in upper panels, and 60 μ m in lower panels. 
In (B) the values are presented as the mean ± SEM (n = 3–4 per group). Different letters indicate statistical 
differences between groups at p < 0.05 level (two-way ANOVA followed by Tukey’s post hoc test).
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in both HYP1 and HYP1 + DEDTC groups, while fish treated with DEDTC alone had a significant decrease in 
the number of transitions to both areas.
Mitochondrial Activities in the Brain. The statistical analyses indicated a significant effect of hypoxia 
(F[3, 27] = 33.423; p < 0.001) and DEDTC (F[3, 27] = 17.901; p < 0.001) on the activity of the mitochondrial 
dehydrogenases (n = 7–9 per group). In fact, animals subjected to hypoxia (HYP1) had decreased mitochon-
drial activities (Fig. 4A) and fish treated with DEDTC after hypoxia (HYP1 + DEDTC) did further decrease this 
parameter. The DEDTC group also showed a significant decline in mitochondrial dehydrogenase activities.
Cerebral Reactive Species. Two-way ANOVA showed a significant effect of hypoxia on the reactive spe-
cies, like nitric oxide (NO•) (F[3, 12] = 24.121; p < 0.001), superoxide anion (O2•−) (F[3, 13] = 5.880; p = 0.031), 
and hydroxyl scavenger capacity (•OH) (F[3, 13] = 56.502; p < 0.001) (n = 4–5 per group). The DEDTC also 
presented substantial effects on the levels of O2•− (F[3, 13] = 17.617; p = 0.001), while a significant interaction 
of hypoxia and DEDTC treatment on •OH scavenger capacity was observed (F[3, 13] = 11.239; p = 0.005). The 
comparison among groups showed that NO• levels (Fig. 4A) increased in animals subjected to hypoxia (HYP1) 
and the treatment with DEDTC after hypoxia (HYP1 + DEDTC) did not reverse this effect. Hypoxic episode 
(HYP1) increased O2•− levels (Fig. 4A), while the fish subjected to hypoxia followed by DEDTC treatment 
(HYP1 + DEDTC) showed similar O2•− content in comparison to control group. The measure of •OH scaven-
ger capacity (Fig. 4A) on each group demonstrated that animals had an elevated content of •OH after hypoxia 
(HYP1), but treatment with DEDTC in animals subjected to hypoxia (HYP1 + DEDTC) did further increase this 
effect.
Brain Antioxidant Responses. The statistical evaluation of antioxidant responses indicated a significant 
effect of DEDTC on sulfhydryl content (SH) (F[3, 14] = 53.519; p < 0.001) (n = 4–5 per group). The post hoc 
analyses showed that animals subjected to hypoxia did not alter SH content (HYP1), while DEDTC exposure 
after hypoxia caused an increase in the thiol levels (HYP1 + DEDTC) (Fig. 4B). Also, the SH content was sub-
stantially elevated in animals only treated with DEDTC. Two-way ANOVA analysis showed a significant effect of 
DEDTC (F[3, 12] = 23.644; p < 0.001) and hypoxia (F[3, 12] = 5.433; p = 0.038) on superoxide dismutase (SOD) 
activity (n = 4–5 per group). The post hoc analyses indicated that hypoxia caused no change in SOD activity 
(HYP1) (Fig. 4B), but treatment with DEDTC in zebrafish subjected to hypoxia resulted in a significant increase 
on enzyme activity.
Discussion
The investigation of new potential drugs that prevent cerebral dysfunctions related to O2 deprivation is stimulated 
due to the elevated number of people affected worldwide. Specifically, the participation of the chelatable Zn in 
the pathophysiology of hypoxia/ischemia has attracted the attention of many researchers. During the ischemic 
and hypoxic episodes, the increased levels of chelatable Zn may induce neurotoxic events, culminating in brain 
damage4,5. Therefore, chemical agents with Zn chelating properties have been considered potential candidates 
as preventive compounds. Here, although DEDTC has exerted chelation of Zn content in the brain, our inves-
tigation on hypoxia model of zebrafish demonstrated harmful effects of DEDTC on exploratory behavior and 
oxidative status (Table 1).
In accordance with previous data15, we showed that hypoxia increased the levels of chelatable Zn in the PGz 
area of zebrafish brain. Furthermore, DEDTC exposure decreased the content of chelatable Zn close to the control 
levels, as previously described in brain hypoxia and ischemic stroke models after administration of Zn chelator5,16. 
Importantly, Zn chelators could decrease the levels of Zn indirectly due to the inhibitory effect on chelatable Zn 
release in CNS. It has been reported that the levels of chelatable Zn are mainly elevated by NO•, a molecule widely 
Figure 2. Exploratory profile of zebrafish after hypoxia followed by treatment, with or without DEDTC. 
(A) The representative track plots illustrating the swimming traces in apparatus. (B) The occupancy plots of 
each experimental group showing the duration in each area of novel tank.
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produced during ischemic events17 and hypoxia5. Based in our results, we suggest that DEDTC acts by direct Zn 
chelation in zebrafish brain since NO• levels remained unchanged after DEDTC treatment.
Specifically, the PGz is a cerebral area of optic tectum with abundant and well-located content of chelatable 
Zn7, being related to visual functions of zebrafish. In fact, chelatable Zn has been identified as important neu-
romodulator in visual pathway of this species18. Because of the intrinsic functions of PGz on visual skills, which 
play a key role in the exploratory profile of zebrafish (e.g. visual acuity), we sought to investigate whether the 
Figure 3. Locomotor activity and vertical exploration after hypoxia followed by normoxic treatment, 
with or without DEDTC. (A) Analysis of basic locomotor paramaters, such as time mobile, distance travelled, 
turn angle, and meandering. (B) Exploration of fish represented as transitions to top and bottom areas of the 
novel tank. Data represent means ± SEM (n = 9–12 per group). Different letters indicate statistical differences 
between groups at p < 0.05 level (two-way ANOVA followed by Tukey’s post hoc test).
Figure 4. Brain effect of hypoxia followed by normoxia, with or without DEDTC, on mitochondrial 
dehydrogenase activities, levels of reactive species and the antioxidant-related responses. (A) Mitochondrial 
activities (n = 7–9 per group), levels of NO•, O2•− and •OH scavenger capacities (n = 4–5 per group). (B) SH 
content and SOD activity (n = 4–5 per group). Data are presented as the means ± SEM. Distinct letters indicate 
statistical differences between groups at p < 0.05 level (two-way ANOVA followed by Tukey’s post hoc test).
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attenuating effect of DEDTC on the content of chelatable Zn in PGz is associated to behavioral activity. Using the 
novel tank test, we confirmed an exploratory deficit caused by hypoxia in zebrafish14, indicating that chelatable Zn 
content in PGz may be an important modulator of these behaviors. It is conceivable that the partial chelation of 
Zn by DEDTC did further exacerbate the exploratory impairments caused by hypoxia, but this effect was similar 
to that observed after DEDTC treatment alone, which did not alter Zn levels in PGz. Therefore, we postulate that 
hypoxia and DEDTC exposure probably modulate distinct mechanisms involved on exploratory deficit of zebraf-
ish: one associated to increased Zn content in PGz (played by hypoxia) and another non-related to Zn content of 
PGz (played by DEDTC).
In this context, we verified whether oxidative stress could have a role on exploratory impairment caused by 
hypoxia and mainly DEDTC. After 1 h of hypoxia episode, fish exhibited a decrease on mitochondrial activities 
and a significant increase in all reactive species assessed, suggesting that mitochondrial damages can have led to 
increased levels of reactive species, such as observed in stroke and other hypoxia models19,20. Importantly, these 
results indicate that both reactive species and exacerbated Zn content in PGz may be involved in exploratory 
deficits induced by hypoxia. Interestingly, the fish exposed to hypoxia and DEDTC showed an attenuating effect 
on O2•− levels, did not show significant changes in NO• levels, but presented exacerbated mitochondrial damage, 
which possibly contributed to the substantial decrease of •OH scavenger capacity. All these findings indicate 
that these fish presented a more critical exploratory deficit due to cumulative effects of hypoxia and DEDTC on 
oxidative stress. These data reinforce the assumption that DEDTC may have triggered a pro-oxidant effect in this 
study. Nevertheless, there are two events that contrast to this hypothesis. Firstly, we observed a lower rather than 
higher O2•− levels in animals exposed to hypoxia and DEDTC. However, as O2•− is a substrate for the production 
of •OH in Haber-Weiss reactions21, these effects could occur simultaneously in animals treated with DEDTC after 
hypoxia, supporting the pro-oxidant action of DEDTC. Finally, DEDTC alone could undermine this hypothesis, 
because mitochondrial damage was not associated to changes in reactive species levels in this experimental group.
Considering that an induction of protective molecules could be responsible for maintaining the normal lev-
els of reactive species in the presence of DEDTC, we investigated the levels of some cellular antioxidants. Even 
with higher levels of reactive species, the animals showed no changes on the antioxidant parameters 1 h after the 
hypoxic episode. It has been reported that the increased activities of antioxidant enzymes (e.g., SOD) in the brain 
occur as a late event in ischemia and hypoxia22,23. We have previously observed that the mitochondrial damage 
generated by hypoxia in the brain of zebrafish is reverted after 48 h, indicating a possible induction of antioxidant 
defenses on this time14. Therefore, our results show that 1 h after hypoxia was ineffective to stimulate these antiox-
idant responses, which certainly contributed for exploratory deficit observed. In contrast, the administration of 
DEDTC increased SOD activity and sulfhydryl content in the brain of animals subjected to hypoxia. Apparently, 
these results support the existence of a balance between reactive species and antioxidants, because these cellular 
defenses were induced in fish with elevate mitochondrial damage and •OH content. If both mechanisms are work-
ing together, it is possible to conclude that antioxidants were insufficient to protect of intense exploratory deficit 
promoted by DEDTC treatment in HYP1 + DEDTC. This fact suggests that even attenuating the increased con-
tent of chelatable Zn, DEDTC probably played a pro-oxidant effect. In accordance with this data, Rahden-Staroń 
et al.12 have shown that the administration of DEDTC on cell culture generates oxidative damage in proteins and 
lipids along with the induction of antioxidant enzymes and production of glutathione. In fact, we verified that 
DEDTC per se promoted a significant increase of sulfhydryl content as a probable response to toxic mechanisms, 
since we observed mitochondrial damage and exploratory deficit in these same animals. Thus, our data reinforce 
the hypothesis that DEDTC presented a pro-oxidant effect in the brain of animals subjected to hypoxia.
Although our results involve at least one putative mechanism by which DEDTC did not reverse the behavio-
ral effects induced by hypoxia, there are some points to be considered in this work. Firstly, we could postulate a 
TYPE PARAMETER DEDTC HYP1 HYP1 + DEDTC
BEHAVIORAL
Time mobile — 0 0
Distance Travelled − − — − − 
Turn angle — — —
Meandering  + 0 + 
Entries to top area — 0 0
Entries to bottom area — 0 0
NEUROCHEMICAL
Chelatable Zn 0 + 0
Mitochondrial activities — — —
Nitric oxide 0 + + 
Superoxide anion 0 + 0
Scavenger capacity (•OH) 0 + + + 
Total Sulphydryl + 0 + 
SOD activity 0 0 + 
Table 1.  Behavioral and neurochemical effects on each experimental group in comparison to control. 
DEDTC: animals kept under normoxia and DEDTC for 1 h; HYP1: animals subjected to hypoxia and kept 
under normoxia for 1 h; HYP1 + DEDTC: animals subjected to hypoxia and kept under normoxia and DEDTC 
for 1 h. (0), no change in relation to control; (− ), reduction in relation to control; ( + ) elevation in relation to 
control.
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protective effect of DEDTC in other concentrations. Indeed, we tested a concentration-response of DEDTC in our 
previous study24, where the higher concentrations of DEDTC (1 and 5 mM) decreased overly the chelatable Zn 
content in the brain of zebrafish, leading to gross behavioral impairments (e.g. seizure-like behavior). In contrast, 
0.2 mM of DEDTC caused smaller effects on zebrafish, representing the highest concentration of DEDTC with 
low cerebral side effects.
Another point to be considered is the opposite effect of DEDTC described in our study in comparison to pre-
vious findings15. Using 0.25 mM DEDTC Yu and Li16 reported an enhanced tolerance to hypoxia associated to a 
neuroprotective action of the compound on chelatable Zn content and mitochondrial activities of zebrafish. We 
hypothesize that these divergent data could be attributed to distinct experimental approaches. For example, in the 
previous work, the mitochondrial activities and chelatable Zn content were evaluated in other recovery periods 
(24 h and 30 min, respectively) and after a DEDTC treatment during highly lethal hypoxic condition (dissolved 
O2 less than 0.8 mg/L). Here, we investigate all parameters associated to behavioral task and oxidative stress under 
a post-hypoxic treatment of DEDTC. Because the underlying relevance for the treatment of disorders associated 
with hypoxia, we adopt the post-hypoxia treatment of DEDTC, which probably determined the results presented 
herein.
In summary, our results showed that hypoxia resulted in abnormally high Zn accumulation in the brain. 
Additionally, DEDTC mitigated the increased Zn content caused by hypoxia, but this effect did further increase 
the behavioral impairments. In an analysis focused on oxidative stress parameters, we reinforced the idea that 
DEDTC performed a pro-oxidant action in animals subjected to hypoxia, which was probably involved in the 
exploratory deficit observed. Therefore, based on a new hypoxia model, our data do not support DEDTC use for 
neuroprotection in dysfunctions involving hypoxia.
Methods
Animals. A total of 160 male and female (50 : 50 ratio) wild-type adult zebrafish (5–7 months-old) were 
obtained from a commercial local distributor (Delphis, RS, Brazil). The animals were kept in aquarium rack sys-
tem (Zebtec, Tecniplast, Italy) under density of 5 fish/L and light/dark cycle of 14/10 h (lights on at 7:00 am) for at 
least 2 weeks prior to the experiments. Fish were fed twice daily with commercial flake fish food (alcon BASIC® , 
Alcon, Brazil) and once a day with Arthemia sp. The experiments were performed using reverse osmosis water 
supplemented with 0.018 g.L−1 Instant Ocean® salt. At these conditions, normoxic water presented 7.5 mg.L−1 O2, 
500 μ S/cm2 of conductivity and pH 7.2. To ensure an adequate aeration in the tanks, the O2 dissolved in water was 
constantly measured with an oximeter (Instrutherm, SãoPaulo, SP, Brazil). All experiments were in accordance 
with National Institute of Health Guide for Care and Use of Laboratory Animals. Experimental protocols were 
approved by Ethics Committee of Universidade Federal do Rio Grande do Sul (number 24471 – CEUA).
Hypoxia Model in Zebrafish. The hypoxia model in zebrafish was performed based in the methods pre-
viously described13,14. Initially, pure N2 was perfused into the water until the dissolved O2 reach 1.5–1.7 mg.L−1. 
Next, two fish were transferred to the hypoxia chamber and the apparatus was hermetically sealed in order to 
provide a closed air tight system. The O2 levels (1.5–1.7 mg.L−1) in the water were continuously monitored by an 
oximeter. Importantly, each hypoxia trial consisted in keeping the fish at low O2 levels up to reach the third stage 
of the hypoxia (maintenance of opercular beats with brief movements), characterized by a critical but non-lethal 
condition14.
Treatment Conditions and Experimental Groups. After hypoxia, each animal was individually kept in 
tanks containing 400 mL of normoxic water (7.5 mg.L−1 O2), in absence or presence of 0.2 mM DEDTC for 1 h. 
This DEDTC concentration was chosen due to low cerebral side effects24 and potential neuroprotective action in 
zebrafish15. Furthermore, the 1 h period was chosen because zebrafish still present behavioral and neurochemical 
changes caused by hypoxia14. Animals were separated in four groups: CONTROL, animals kept under normoxia 
for 1 h; DEDTC, animals kept under normoxia and DEDTC for 1 h; HYP1, animals subjected to hypoxia and 
kept under normoxia for 1 h; and HYP1 + DEDTC, animals subjected to hypoxia and kept under normoxia and 
DEDTC for 1 h. Importantly, the normoxic levels of O2 in the water were kept constant during treatments (7.5 mg.
L−1 O2). After treatments, fish were anesthetized using ice-cold water and euthanatized by decapitation to remove 
the brain.
Histochemical Quantification of Chelatable Zn in the Brain. The chelatable Zn content from PGz 
was histochemically stained by Neo-Timm method, as performed in zebrafish brain7. The PGz was evaluated 
due to its abundant content of chelatable Zn and its intrinsic relation with optic tectum, which plays a role in 
zebrafish visual processing. Briefly, brains were immediately immersed in 3% glutaraldehyde containing 0.1 M 
phosphate buffer (pH 7.4) for 24 h, and then transferred to sodium sulfide solution (1% Na2S) containing 0.12 M 
Millonig’s buffer for 24 h. Slices (30-μ m-thick) were produced in vibroslicer (VTS-1000;Leica), and mounted on 
slides. The histochemical staining was performed by incubation of the slices in a solution containing 120 mL of 
50% gum Arabic, 30 mL of hydroquinone (1.85 g), 20 mL of citric acid (5.12 g) plus sodium citrate (4.72 g), and 
1 mL of silver nitrate (0.17 g) for 120 min. The reaction was performed in a dark room, and only ultrapure and 
metal-free solutions were used. The NIS Elements AR 2.30 software (Nikon) was used to capture the images from 
a light microscope (Nikon Eclipse E-600) coupled with a camera (Nikon DXM1200C CCD). The optical density 
of the total area of the PGz of zebrafish was determined to quantify chelatable Zn stained by Neo-Timm under 
10x magnification using ImageJ 1.37v software. The results were expressed in arbitrary units (a.u.) followed by a 
normalization in relation to the control.
Novel Tank Test. After treatments, the behavioral activity of some fish was evaluated by the novel tank as 
previously described25. The apparatus consisted in a plastic tank (23.9 cm along the bottom x 28.9 cm at the top 
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x 15.1 cm high) virtually divided into three horizontal areas (bottom, middle, and top) and with five sections 
per area. The tank was filled with 1.5 L of normoxic water and placed on a stable surface with all environmental 
interferences kept to a minimum. Animals were individually transferred to the novel tank and their behavior was 
recorded for 6 min. The swimming activity was acquired by a webcam (Microsoft® LifeCam 1.1 with Auto-Focus) 
and all behavioral parameters were measured by video tracking software at 30 frames/s (ANY-maze®, Stoelting 
CO, USA). The locomotor activity was assessed by measuring the total time mobile, distance travelled, turn angle 
(the variations in direction of the center point of the animal), and meandering (turn angle divided by distance 
travelled). Since the zebrafish tend to gradually explore upper areas in a novel apparatus26, the vertical exploration 
was also evaluated by measuring the number of transitions in top and bottom areas. All tests were performed 
during the same time frame each day (10:00 am - 4:00 pm), and the water was replaced every session.
Measurement of the Mitochondrial Activities in the Brain. The activities of brain mitochondrial 
dehydrogenases were evaluated by the level of formazan produced from 2,3,5-triphenyltetrazolium chloride 
(TTC)14. The whole brains were incubated in 1 mL of phosphate buffer solution (PBS, pH 7.4) containing 2% TTC 
(Sigma–Aldrich, St. Louis, MO, USA) at 37 °C for 40 min in dark room. Next, TTC was removed and 10% forma-
lin dissolved in PBS (pH 7.4) was added in order to terminate the reaction. The brains were dried at 40 °C for 2 h 
and separately weighed in an analytical balance. Then, each brain was incubated with 200 μ L of dimethylsulfoxide 
(DMSO) (Sigma–Aldrich, St. Louis, MO, USA) in 96 wells plates protected from light. The plates were kept under 
constant agitation for 4 h to solubilize the formazan produced from TTC. The pink-to-red eluate of formazan was 
read at 490 nm in a microplate reader and the data were expressed in absorbance per tissue dry weight (g).
Oxidative Status in the Brain. Four brains were pooled (1n = 4 brains) to measure NO•, O2•−, •OH, SH, 
and SOD activity. Due to the unequal amount of samples needed to perform each technique, the use of pooled 
brains allowed the analysis of all oxidative stress parameters by using a smaller number of animals. The samples 
were immediately kept on ice and were freshly homogenized (1:20, w/v) in 20 mM sodium phosphate buffer, pH 
7.4 containing 140 mM KCl. The homogenates were centrifuged at 800 g for 10 min at 4 °C to separate nuclei and 
cell debris. Protein content was measured according to Lowry et al.27 using bovine albumin as standard. The anal-
yses of oxidative stress parameters and protein content were run in duplicate.
Evaluation of Reactive Species. The O2•− levels were detected by measuring the chemiluminescence of 
lucigenin based in previous works28,29. The supernatants (50 μ L) were added in medium reaction (100 μ L) with 
Krebs HEPES buffer in the presence of lucigenin (20 μ mol/L). Since hypoxia induces an increase in O2•−, the 
maximum acceptable concentration of lucigenin was used in order to increase sensitivity of the detection of 
O2•− without artificial self-generation of O2•− in the samples30. The luminescence of samples was evaluated in 
a luminescence counter (Perkin Elmer, MicroBeta TriLux) for 10 min. Values of blank chambers containing the 
same reagents were recorded as background, which were subtracted from those from their corresponding sam-
ples. The data were normalized to tissue weight and expressed in RLU (relative luminescence unit)/min/mg tissue.
Nitric oxide content was assessed from Griess reaction using a protocol based on Green et al.31. The incubation 
was performed in 96-well plates containing 50 μ L of supernatant and 50 μ L of Griess reagent (1:1 mixture of 1% 
sulfanilamide in 5% phosphoric acid and 0.1% dihydrochloride naphthylethylenediamine in water). A standard 
curve of NO• was obtained with known concentrations of nitrite (1.5–100 μ M). Plates were protected from light 
and kept at room temperature for 10 min. The absorbance was measured at 543 nm and nitrite concentration was 
represented as μ mol of nitrite/mg protein.
The deoxyribose assay was used to evaluate the •OH production from the auto-reduction of ferric citrate 
complex32. Briefly, the pentose is attacked by •OH with releasing thiobarbituric acid (TBA) reactive substances. 
The samples (25 μ L of supernatant) were incubated at 37 °C for 1 h in dark room with a medium containing 3 mM 
2-deoxy-D-ribose, 20 μ M FeCl3, 100 μ M EDTA, 500 μ M H2O2 and 100 μ M ascorbate. Afterwards, 10% TCA and 
0.67% TBA were added and incubated for 1 h in boiling water bath. The absorbance was determined at 532 nm 
and 1,1,3,3-tetra-methoxypropane (TMP) was used as standard. The results were expressed as μ mol TMP/mg 
protein.
Antioxidant Analysis. The assay of sulfhydryl content was based on the reduction of 
5,5′ -dithio-bis(2-nitrobenzoic acid) (DTNB) by thiols33. Briefly, 14 μ L of homogenate were added to 270 μ L of 
PBS (0.1 M, pH 7.4) containing 1 mM EDTA. Then, 16 μ L of PBS containing 10 mM DTNB were added. Controls 
without DTNB or samples were conducted simultaneously. Subsequently, a 30-min incubation was performed 
at room temperature in a dark room. The absorption was measured at 412 nm and the results were presented as 
nmol TNB/mg protein.
The superoxide dismutase activity was analyzed by autoxidation capacity of pyrogallol as obtained in 
Marklund method34. The inhibition of pyrogallol autoxidation occurs by SOD activity, which is determined in a 
medium containing 15 μ L of sample and 235 μ L of a solution of 50 mM Tris-HCl (pH 8.2), 1 mM EDTA, 30 μ M 
catalase, and 24 mM pyrogallol. The product was read at 420 nm. The inhibition of pyrogallol autoxidation (50%) 
was defined as one unit of SOD and the specific activity was expressed as units/mg protein.
Statistical analysis. The values were expressed as means ± SEM. The behavioral and neurochemical param-
eters were analyzed by two-way ANOVA, using hypoxia and DEDTC treatment as factors. Post hoc comparisons 
were performed by Tukey’s test. Statistical significance was set at p < 0.05 level.
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